1. Home
  2. ICE vs SNY Comparison

ICE vs SNY Comparison

Compare ICE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercontinental Exchange Inc.

ICE

Intercontinental Exchange Inc.

HOLD

Current Price

$125.06

Market Cap

87.5B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$41.66

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICE
SNY
Founded
2000
1994
Country
United States
France
Employees
N/A
74846
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5B
104.5B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ICE
SNY
Price
$125.06
$41.66
Analyst Decision
Strong Buy
Buy
Analyst Count
9
5
Target Price
$194.78
$58.00
AVG Volume (30 Days)
4.5M
3.5M
Earning Date
04-30-2026
04-23-2026
Dividend Yield
1.33%
3.47%
EPS Growth
20.71
N/A
EPS
2.48
N/A
Revenue
$5,834,000,000.00
N/A
Revenue This Year
$10.29
$3.49
Revenue Next Year
$4.76
$6.10
P/E Ratio
$50.19
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$124.37
$40.89
52 Week High
$189.35
$52.68

Technical Indicators

Market Signals
Indicator
ICE
SNY
Relative Strength Index (RSI) 22.76 38.68
Support Level N/A N/A
Resistance Level $161.54 $48.76
Average True Range (ATR) 3.75 0.71
MACD -0.89 -0.22
Stochastic Oscillator 0.61 18.97

Price Performance

Historical Comparison
ICE
SNY

About ICE Intercontinental Exchange Inc.

Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data-services segment (24% of net revenue).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: